0001567619-18-001687.txt : 20180823 0001567619-18-001687.hdr.sgml : 20180823 20180823085152 ACCESSION NUMBER: 0001567619-18-001687 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180803 FILED AS OF DATE: 20180823 DATE AS OF CHANGE: 20180823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richard Ronald CENTRAL INDEX KEY: 0001380177 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 181033768 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2018-08-03 0 0001367644 Emergent BioSolutions Inc. EBS 0001380177 Richard Ronald 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2018-08-03 4 M 0 100 14.71 A 21063 D Common Stock 2018-08-03 4 S 0 100 60.00 D 20963 D Common Stock 2018-08-21 4 M 0 7793 14.71 A 28756 D Common Stock 2018-08-21 4 S 0 7793 60.0166 D 20963 D Stock Option (Right to Buy) 14.71 2018-08-03 4 M 0 100 14.71 D 2020-05-19 Common Stock 100 7793 D Stock Option (Right to Bury) 14.71 2018-08-21 4 M 0 7793 14.71 D 2020-05-19 Common Stock 7793 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to 60.05, inclusive. Consists of an option granted under the company's stock incentive plan as amended and restated. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. /s/ S. Scott Lieberman, Attorney-in-fact 2018-08-23